Labviva, the leading AI procurement platform for life sciences, announced the close of its $25 million Series B, bringing its total funding to $55 million. Led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the investment reflects the company’s boom growth and escalating demand in Biopharma for automated supply chain and procurement solutions. As part of the fundraising, 53 Station’s Co-Founder and Managing Partner, Jason Pritzker, will join Labviva’s Board of Directors.

“Successful AI companies deliver enormous efficiencies with the right balance of speed, scale, and human-AI collaboration. This year, Labviva did just that, transitioning from the industry’s ‘best kept secret’ to the go-to resource for accelerating the pace of science,” said Jason Pritzker. “Labviva is transforming supply chain and procurement for life sciences and I’m delighted to help guide and support their next phase of growth.”

The use of AI in life sciences is forecasted to reach $11 billion by 2033, predominantly driven by pharmaceutical and biotech adoption. According to MIT Technology Review Insights, the life sciences sector has “gone all in on AI,” with major pharmaceutical companies implementing AI across the enterprise to improve business processes such as research, legal, and drug discovery and development. To this end, Labviva enhances research operations by applying AI to drive efficiencies in labs, ultimately saving scientists time and money while speeding research innovation.

“We’ve been laser focused on building close customer and supplier relationships and deploying solutions that drive instant, long-term results. This strategy paid off because today, we’ve reached an inflection point that positions Labviva for massive growth,” said Siamak Baharloo, CEO & Co-Founder, Labviva. “With 53 Stations’ deep operational expertise, support from The Pritzker Organization, and continued backing from other investors, we plan to thrive by fueling new innovations, driving customer success, and entering new markets.”